Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. - Wikidata - awgldk - TriplyDB

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

http://www.wikidata.org/entity/Q34450243

about

Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials.Clinical trial design of serious gaming in mild cognitive impairment.The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.Measuring cognition and function in the preclinical stage of Alzheimer's disease.

P2860

Q30994007-85A1F3C8-CE13-4E9C-8D1A-8197E3A369D0 Q35166837-1DD23B68-B8D7-4F2D-BCC9-4A4AC1836009 Q52585260-07C170FE-EB09-4942-9462-761E0D0BB20A Q55442237-F098CF39-19D5-4CD5-9D57-41CFD1DE534A

P2860

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

http://www.wikidata.org/entity/Q34450243

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@ast

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@en

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@nl

type

label

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@ast

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@en

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@nl

prefLabel

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@ast

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@en

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@nl

P1433

Q34450243-EAAA8C3B-FF4F-4B04-B4FA-28369FB04AB1

P1476

Q34450243-DAF8B789-C171-49AD-86EC-DDA07E64B521

P2093

Q34450243-5E68623E-ED30-41BD-AFF9-6CB312B62866

Q34450243-6045E52F-7F00-494F-8E90-4DABF2F5E725

Q34450243-A1F5D902-433F-4AAF-9A24-C19BC0FCECA3

Q34450243-B2F638A9-8C89-4883-ACDA-0B8D821D3630

Q34450243-B8764B7C-EDE6-4551-8AB8-519D0C776582

Q34450243-BC3E9054-6B1A-4787-A504-C5814C907D45

Q34450243-D99177D7-8AFF-4811-AA0D-A38C5C49DE1A

Q34450243-F0990287-3214-4FFF-ACB0-430B2F600BD1

Q34450243-F30163E3-AE6A-495C-8CC3-C4C972EEE97E

P2860

Q34450243-00778843-C046-4C93-8EC2-3DF87F927486

Q34450243-01674ABC-17DD-446D-8B2D-00438D68BF58

Q34450243-043CCBAF-CD99-4FB9-A29D-3552C16C0A10

Q34450243-066B66BB-12E3-40C1-B5C8-A8867A687DA0

Q34450243-0AF687AE-DA18-413B-BE9E-A6719D003B6B

Q34450243-1A0F6E35-3AAE-4F8C-B57B-2755F5C011BD

Q34450243-1A64E98D-7083-45A3-9A6A-4D2AB4789175

Q34450243-28769CE6-53C6-4FBD-8380-7FE70853D3AB

Q34450243-39A66139-4BF0-433B-97B2-1B5601DBE705

Q34450243-3C10D135-E48C-46C9-B523-B9D7DA05674D

P304

Q34450243-BA4C91AB-80D5-4095-B9F6-181C76AB5565

P31

Q34450243-C0A1257C-1A73-4158-BB12-C3882E0CC620

P356

Q34450243-5500DD8B-6E46-4BC8-8818-A85469D972AC

P407

Q34450243-02EA0E28-D5AC-459D-ADAA-81DF9F8C0FF0

P433

Q34450243-D03F87BD-2CCE-4966-930A-18E47B25E8A4

P478

Q34450243-E75C11CF-D311-4AD3-8F6F-4FD6D08652BE

P50

Q34450243-06665E91-5066-4317-B594-248F59F198BC

Q34450243-51E4A03B-D633-4FEB-928F-2C05B4882094

Q34450243-A0BBDE5E-211B-4721-9421-4BC3CDD71B97

Q34450243-B4F05071-4BA4-4B4A-B500-47C72C48A1C0

P577

Q34450243-5F295B04-4D56-4013-B7C9-C230F06E184B

P5875

Q34450243-D0CF5DB6-45A4-490E-B86F-9DDBAD7EB347

P698

Q34450243-3379D052-2D90-447B-9E63-691B14E97CE7

P921

Q34450243-0E499FD5-1C12-40AB-A3FC-07145970C33D

P932

Q34450243-2C78BA5C-C869-436E-9535-493E02B51517

P356

WAD.0000000000000071

P1433

Alzheimer Disease and Associated Disorders

P1476

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

@en

P2093

Anna Caroli

http://www.w3.org/2001/XMLSchema#string

Annapaola Prestia

http://www.w3.org/2001/XMLSchema#string

Cathleen Haense

http://www.w3.org/2001/XMLSchema#string

Cindee M Madison

http://www.w3.org/2001/XMLSchema#string

Karl Herholz

http://www.w3.org/2001/XMLSchema#string

Kewei Chen

http://www.w3.org/2001/XMLSchema#string

Napatkamon Ayutyanont

http://www.w3.org/2001/XMLSchema#string

Susan M Landau

http://www.w3.org/2001/XMLSchema#string

William J Jagust

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Clinical trial methodologies for disease-modifying therapeutic approaches

Mild cognitive impairment: clinical characterization and outcome

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Magnetic resonance imaging in clinical trials.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

P304

101-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WAD.0000000000000071

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni B. Frisoni

Alzheimer's Disease Neuroimaging Initiative

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269115265

http://www.w3.org/2001/XMLSchema#string

P698

25437302

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4437812

http://www.w3.org/2001/XMLSchema#string